Weekly Analysts’ Ratings Changes for Intuitive Surgical (ISRG)

A number of research firms have changed their ratings and price targets for Intuitive Surgical (NASDAQ: ISRG):

• 10/18/2024 – Intuitive Surgical was given a new $604.00 price target on by analysts at The Goldman Sachs Group, Inc..
• 10/18/2024 – Intuitive Surgical had its “market perform” rating reaffirmed by analysts at Oppenheimer Holdings Inc..
• 10/18/2024 – Intuitive Surgical had its “cautious” rating reaffirmed by analysts at Evercore ISI.
• 10/18/2024 – Intuitive Surgical was given a new $535.00 price target on by analysts at BTIG Research.
• 10/18/2024 – Intuitive Surgical had its price target raised by analysts at Wells Fargo & Company from $466.00 to $549.00. They now have an “overweight” rating on the stock.
• 10/18/2024 – Intuitive Surgical had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $538.00 price target on the stock, up previously from $495.00.
• 10/18/2024 – Intuitive Surgical had its price target raised by analysts at Royal Bank of Canada from $525.00 to $555.00. They now have an “outperform” rating on the stock.
• 10/18/2024 – Intuitive Surgical had its price target raised by analysts at Evercore ISI from $475.00 to $490.00. They now have an “in-line” rating on the stock.
• 10/18/2024 – Intuitive Surgical had its price target raised by analysts at Stifel Nicolaus from $475.00 to $525.00. They now have a “buy” rating on the stock.
• 10/17/2024 – Intuitive Surgical had its price target raised by analysts at Robert W. Baird from $503.00 to $565.00. They now have an “outperform” rating on the stock.
• 10/17/2024 – Intuitive Surgical had its price target raised by analysts at Mizuho from $440.00 to $500.00.
• 10/17/2024 – Intuitive Surgical had its price target raised by analysts at Leerink Partners from $489.00 to $502.00.
• 10/14/2024 – Intuitive Surgical had its price target raised by analysts at Raymond James from $500.00 to $540.00. They now have an “outperform” rating on the stock.
• 10/14/2024 – Intuitive Surgical had its price target raised by analysts at BTIG Research from $494.00 to $518.00. They now have a “buy” rating on the stock.
• 10/14/2024 – Intuitive Surgical had its price target raised by analysts at Truist Financial Co. from $520.00 to $570.00. They now have a “buy” rating on the stock.
• 10/11/2024 – Intuitive Surgical had its price target raised by analysts at JPMorgan Chase & Co. from $495.00 to $575.00. They now have an “overweight” rating on the stock.
• 10/8/2024 – Intuitive Surgical had its price target raised by analysts at Royal Bank of Canada from $515.00 to $525.00. They now have an “outperform” rating on the stock.
• 10/1/2024 – Intuitive Surgical had its price target raised by analysts at Evercore ISI from $410.00 to $475.00. They now have an “in-line” rating on the stock.
• 8/28/2024 – Intuitive Surgical had its price target raised by analysts at BTIG Research from $469.00 to $494.00. They now have a “buy” rating on the stock.

Intuitive Surgical Stock Down 0.1 %

ISRG stock traded down $0.46 during midday trading on Friday, reaching $511.17. 464,646 shares of the company’s stock traded hands, compared to its average volume of 1,466,976. The company has a 50-day simple moving average of $486.71 and a two-hundred day simple moving average of $440.96. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34. The company has a market cap of $181.31 billion, a price-to-earnings ratio of 92.27, a PEG ratio of 5.40 and a beta of 1.39.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $446.60, for a total transaction of $167,921.60. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,458,979.60. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $446.60, for a total value of $167,921.60. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,458,979.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 52,192 shares of company stock valued at $25,398,571 over the last three months. 0.90% of the stock is owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of large investors have recently added to or reduced their stakes in ISRG. Mirador Capital Partners LP boosted its position in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. lifted its position in Intuitive Surgical by 18.1% during the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after buying an additional 1,129 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after buying an additional 76,649 shares during the last quarter. Brookstone Capital Management increased its position in shares of Intuitive Surgical by 22.4% in the second quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after acquiring an additional 2,289 shares during the last quarter. Finally, M&G Plc boosted its holdings in shares of Intuitive Surgical by 53.5% in the 2nd quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock valued at $2,256,000 after buying an additional 1,766 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.